An exuberant market that may have not fully appreciated the challenges in the rollout of vaccines and newer strains of the COVID-19 virus may provide an opportune time to rotate into relatively undervalued assets, according to investment experts. On Wednesday, the broadest measure of Japanese stocks, the Nikkei 500, added 0.7% to already record highs. This was despite Japanese Prime…
Exclusive
A stitch in time in an exuberant market could save capital
3 February 2021

Photo by Tmaximumge form PxHere
Share Article
Share Article
Related News

Bank of Singapore hires new team head for Taiwan market
29 April 2022

Asia market volatility boosts case for our DPM: UBS GWM’s Adrian Zuercher
30 March 2022

Chinese equities pummeled by headwinds: PBs explain the stock market rout
16 March 2022

How Blue Owl Capital hopes to tap into growing appetite for alts among Asia’s wealthy
16 February 2022

Exclusive
CIO Weekly – DiDi delisting story is only market noise: Arjan de Boer of Indosuez WM
9 December 2021

Exclusive
Eurizon Capital eyes Greater China business
12 November 2021

Exclusive
Caught between a rock and a hard place? Seek Asian high-yield: Hou Wey Fook of DBS
28 September 2021

Exclusive
Evergrande woes spark global market turmoil
21 September 2021

Exclusive
Bracing for a market correction? Arjan de Boer of Indosuez WM says he has you covered
13 September 2021

Exclusive
CIO Weekly – Chinese regulators aim to develop the domestic capital market infrastructure: Eli Lee of Bank of Singapore
19 August 2021

Pictet Wealth Management names new SA market leader, NA market group head amid raft of Asia appointments
24 June 2021

PE/VC funds push Australian private capital industry to A$77B in AUM
25 May 2021